Detalhe da pesquisa
1.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320921
2.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548583
3.
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Br J Haematol
; 185(3): 480-491, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793290
4.
Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma.
Support Care Cancer
; 26(4): 1253-1264, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116407
5.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Biol Blood Marrow Transplant
; 23(1): 53-59, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27771496
6.
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Biol Blood Marrow Transplant
; 23(10): 1631-1640, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533060
7.
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
Br J Haematol
; 178(5): 699-708, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782811
8.
Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study.
Br J Haematol
; 186(1): 168-170, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656671
9.
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Br J Haematol
; 167(3): 327-36, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066542
10.
Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
Br J Haematol
; 164(5): 668-74, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24274082
11.
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Blood
; 130(15): 1772-1774, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801448
12.
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.
Haematologica
; 98(3): 357-63, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065525
13.
First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.
Haematologica
; 98(10): 1563-70, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23753021
14.
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.
Hematol Oncol
; 36(5): 765-772, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129233
15.
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.
Blood
; 116(8): e12-7, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479282
16.
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 97(2): 310-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993674
17.
Coexistence of Langerhans cell histiocytosis, Rosai-Dorfman disease and splenic lymphoma with fatal outcome after rapid development of histiocytic sarcoma of the liver.
J Cutan Pathol
; 39(12): 1125-30, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23043641
18.
BCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival.
Leuk Lymphoma
; 63(1): 101-108, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510996
19.
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
Int J Hematol
; 116(3): 381-392, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551632
20.
Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.
Haematologica
; 95(7): 1176-82, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20107156